tiprankstipranks
Trending News
More News >
Pharma Mar SA (ES:PHM)
BME:PHM
Spanish Market

Pharma Mar SA (PHM) Financial Statements

Compare
18 Followers

Pharma Mar SA Financial Overview

Pharma Mar SA's market cap is currently €1.41B. The company's EPS TTM is €-0.13; its P/E ratio is 41.18; and it has a dividend yield of 1.04%. Pharma Mar SA is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is €2.37. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue€ 174.85M€ 158.15M€ 196.34M€ 229.83M€ 269.96M
Gross Profit€ 166.67M€ 148.54M€ 182.70M€ 213.39M€ 256.24M
Operating Income€ 6.47M€ -3.83M€ 44.07M€ 92.45M€ 155.94M
EBITDA€ 21.23M€ 4.55M€ 52.07M€ 104.08M€ 155.94M
Net Income€ 26.13M€ 1.14M€ 49.36M€ 92.86M€ 137.26M
Balance Sheet
Cash & Short-Term Investments€ 154.53M€ 162.56M€ 182.42M€ 201.88M€ 195.52M
Total Assets€ 349.64M€ 340.52M€ 393.26M€ 368.39M€ 330.26M
Total Debt€ 51.08M€ 43.67M€ 42.63M€ 49.33M€ 56.66M
Net Debt€ -12.16M€ -16.36M€ -107.18M€ -64.02M€ -39.55M
Total Liabilities€ 141.28M€ 147.08M€ 170.30M€ 190.47M€ 227.54M
Stockholders' Equity€ 208.36M€ 193.44M€ 222.96M€ 177.92M€ 102.72M
Cash Flow
Free Cash Flow€ -9.48M€ -29.40M€ 29.47M€ 17.87M€ 275.94M
Operating Cash Flow€ 6.03M€ -13.45M€ 38.32M€ 25.68M€ 278.94M
Investing Cash Flow€ 1.03M€ -43.05M€ 10.88M€ 18.47M€ -119.01M
Financing Cash Flow€ -5.35M€ -32.14M€ -13.37M€ -27.41M€ -73.82M
Currency in EUR

Pharma Mar SA Earnings and Revenue History

Pharma Mar SA Debt to Assets

Pharma Mar SA Cash Flow

Pharma Mar SA Forecast EPS vs Actual EPS